Micro RNA (miRNA) nanoparticle formulation for efficient and traceable transfection of cells

Researchers have developed and patented a biodegradable and biocompatible nanoparticle formulation for efficient intracellular delivery and integration of miRNAs that can also be tracked by magnetic resonance imaging (fluorine radiotracer). This is a powerful enabling tool kit for the expanding market in gene-based medicines and other potential applications. These nanoparticles are well-suited to RNA drug delivery systems, having high drug loading capacity, stability (in aqueous environments and for long-term storage); they
are also non-toxic and non-immunogenic. The incorporation of an imaging agent in the formulation (such as perfluorocarbon) allows monitoring of nanoparticle transfection efficiency and bio distribution. This technology could potentially provide an alternative route for transfecting cells in vivo that does not rely on competing proprietary methods that are currently in commercial use, such as lipid nanoparticles and adeno- associated virus (AAV).

Attached files:
Figure1.pdf

Patents:
EP 27,907,391 issued 2012-08-08   [MORE INFO]

Type of Offer: Sale or Licensing



Next Patent »
« More Pharmaceutical Patents
« More Diagnostic Patents

Share on      


CrowdSell Your Patent